WADA Prohibition The World Anti-Doping Agency classifies multiple components as prohibited substances: BPC-157: Listed under Section S0 (Non-Approved Substances), prohibited at all times TB-500: Listed under S2: Peptide Hormones, Growth Factors, prohibited at all times GHK-Cu: Not specifically prohibited but peptide combinations generally scrutinized KPV: Not explicitly listed but could fall under similar chemical structure provisions No Therapeutic Use Exemptions (TUEs) available for any prohibited components Combined formulations would fall under multiple prohibited categories Detection methods developed for BPC-157 (up to 4 days) and TB-500 WADAs prohibition reflects the lack of regulatory approval from health authorities worldwide for these peptides and concerns about tissue-regenerative and performance-enhancing properties

Such incomplete penetrance is not only the rule for all 22q11DS-associated phenotypes (e.g., ~25% of individuals with 22q11DS do not have a congenital cardiac anomaly [1]), it is also the prevailing phenotypic pattern observed for virtually all other rare, high-impact variants [123]
This metabolic enhancement, while modest compared to the robust appetite suppression effects, provides an additional mechanism contributing to the compound's exceptional weight loss efficacy
In the same infertility study discussed above, researchers tested NAC alone, selenium alone, and the combination of both ingredients